Safety analysis of eight patients treated with erlotinib after severe gefitinib-induced liver injury

Gan to Kagaku ryoho. Cancer & Chemotherapy, 2010 - europepmc.org
Gefitinib and erlotinib are commercially available epidermal growth factor receptor tyrosine
kinase inhibitors (EGFR-TKIs) that are widely used for the treatment of non-small-cell lung …
被引用次数：10 相关文章

Safety analysis of eight patients treated with erlotinib after severe gefitinib-induced liver injury

Y Ohashi, K Suzuki, M Sakurai… - Gan to kagaku …, 2010 - pubmed.ncbi.nlm.nih.gov
Gefitinib and erlotinib are commercially available epidermal growth factor receptor tyrosine
kinase inhibitors (EGFR-TKIs) that are widely used for the treatment of non-small-cell lung …

[引用][C] Safety Analysis of Eight Patients Treated with Erlotinib after Severe Gefitinib-Induced Liver Injury

Y OHASHI, K SUZUKI, M SAKURAI, H ISHIKAWA…